Department of Optometry and Vision Sciences, The University of Melbourne, Melbourne, Australia.
Biostatistics Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Cochrane Database Syst Rev. 2021 Feb 18;2(2):CD013390. doi: 10.1002/14651858.CD013390.pub2.
Infantile nystagmus syndrome (INS) is a type of eye movement disorder that can negatively impact vision. Currently, INS cannot be cured, but its effects can potentially be treated pharmacologically, optically, or surgically. This review focuses on the surgical interventions for INS. Despite the range of surgical interventions available, and currently applied in practice for the management of INS, there is no clear consensus, and no accepted clinical guidelines regarding the relative efficacy and safety of the various treatment options. A better understanding of these surgical options, along with their associated side effects, will assist clinicians in evidence-based decision-making in relation to the management of INS.
To assess the efficacy and safety of surgical interventions for INS.
We searched CENTRAL, MEDLINE Ovid, Embase Ovid, ISRCTN registry, ClinicalTrials.gov, and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) to 3 July 2020, with no language restrictions.
We included randomised controlled trials (RCTs) studying the efficacy and safety of surgical options for treating INS.
Our prespecified outcome measures were the change from baseline in: binocular best-corrected distance visual acuity; head posture; amplitude, frequency, intensity, and foveation period durations of the nystagmus waveform; visual recognition times; quality of life and self-reported outcome measures; incidence of adverse effects with a probable causal link to treatment; and permanent adverse effects after surgery. Two review authors independently screened titles and abstracts and full-text articles, extracted data from eligible RCTs, and judged the risk of bias using the Cochrane tool. We reached consensus on any disagreements by discussion. We summarised the overall certainty of the evidence using the GRADE approach.
We only identified one eligible RCT (N = 10 participants), undertaken in India. This trial randomised participants to receive either a large retro-equatorial recession of the horizontal rectus muscle of 9 mm on the medial rectus and 12 mm on the lateral rectus, or a simple tenotomy and resuturing of the four horizontal rectus muscles. We did not identify any RCTs comparing a surgical intervention for INS relative to no treatment. In the single eligible RCT, both eyes of each participant received the same intervention. The participants' age and gender were not reported, nor was information on whether participants were idiopathic or had sensory disorders. The study only included participants with null in primary position and did not explicitly exclude those with congenital periodic alternating nystagmus. The study did not report funding source(s) or author declaration of interests. The evaluation period was six months. We judged this study at low risk for sequence generation and other sources of bias, but at high risk of bias for performance and detection bias. The risk of bias was unclear for selection bias, attrition bias, and reporting bias. There is very uncertain evidence about the effect of the interventions on visual acuity and change in amplitude, frequency, and intensity of the nystagmus waveform. We were unable to calculate relative effects due to lack of data. None of the participants in either intervention group reported adverse effects at six-month follow-up (very low-certainty evidence). There was no quantitative data reported for quality of life, although the study reported an improvement in quality of life after surgery in both intervention groups (very low-certainty evidence). Change in head posture, foveation period durations of the nystagmus waveform, visual recognition times, and permanent adverse effects after surgery were not reported in the included study. We judged the certainty of the evidence, for both the primary and secondary efficacy outcomes, to be very low. Due to a lack of comprehensive reporting of adverse events, there was also very low-certainty of the safety profile of the evaluated surgical interventions in this population. As such, we are very uncertain about the relative efficacy and safety of these interventions for the surgical management of INS.
AUTHORS' CONCLUSIONS: This systematic review identified minimal high-quality evidence relating to the efficacy and safety of surgical interventions for INS. The limited availability of evidence must be considered by clinicians when treating INS, particularly given these procedures are irreversible and often performed on children. More high-quality RCTs are needed to better understand the efficacy and safety profile of surgical interventions for INS. This will assist clinicians, people with INS, and their parents or caregivers to make evidence-based treatment decisions.
婴儿性眼球震颤综合征(INS)是一种眼球运动障碍,可能会对视力产生负面影响。目前,INS 无法治愈,但可以通过药理学、光学或手术进行治疗。本综述重点关注 INS 的手术干预措施。尽管有多种手术干预措施,并且目前在实践中用于管理 INS,但目前尚无明确的共识,也没有关于各种治疗方案相对疗效和安全性的公认临床指南。更好地了解这些手术选择及其相关副作用,将有助于临床医生在 INS 管理方面做出基于证据的决策。
评估 INS 手术干预的疗效和安全性。
我们检索了 CENTRAL、MEDLINE Ovid、Embase Ovid、ISRCTN 注册中心、ClinicalTrials.gov 和世界卫生组织(WHO)国际临床试验注册平台(ICTRP),截至 2020 年 7 月 3 日,无语言限制。
我们纳入了研究 INS 治疗中手术选择疗效和安全性的随机对照试验(RCT)。
我们预先指定的结局指标是:双眼最佳矫正距离视力的变化;头位;眼球震颤波形的振幅、频率、强度和注视期持续时间;视觉识别时间;生活质量和自我报告的结局测量;与治疗有因果关系的不良事件发生率;以及手术后的永久性不良事件。两名综述作者独立筛选标题和摘要以及全文文章,从合格的 RCT 中提取数据,并使用 Cochrane 工具评估偏倚风险。我们通过讨论达成了对任何分歧的共识。我们使用 GRADE 方法总结了证据的总体确定性。
我们仅确定了一项符合条件的 RCT(N = 10 名参与者),该试验在印度进行。该试验将参与者随机分配接受内侧直肌 9 毫米、外侧直肌 12 毫米的大 retro-equatorial 后退性横向直肌切除术,或四直肌简单切开再缝合术。我们没有发现任何 RCT 比较 INS 的手术干预与不治疗。在唯一一项合格的 RCT 中,每个参与者的双眼都接受了相同的干预。参与者的年龄和性别、是否为特发性或有感觉障碍的信息、以及是否包括先天性周期性交替性眼球震颤的信息均未报告。该研究仅包括原发性眼位无斜视的参与者,并且没有明确排除先天性周期性交替性眼球震颤的患者。该研究没有报告资金来源或作者利益声明。评估期为六个月。我们判断这项研究在随机序列生成和其他偏倚来源方面的风险较低,但在执行和检测偏倚方面的风险较高。选择偏倚、失访偏倚和报告偏倚的风险不明确。关于这些干预措施对视力和眼球震颤波形振幅、频率和强度变化的影响,我们只有非常不确定的证据。由于缺乏数据,我们无法计算相对效果。在六个月的随访中,干预组的参与者均未报告不良反应(极低确定性证据)。虽然研究报告了两组手术组的生活质量改善(极低确定性证据),但没有报告生活质量的定量数据。头位、眼球震颤波形注视期持续时间、视觉识别时间和手术后永久性不良事件的变化在纳入的研究中没有报告。我们判断主要和次要疗效结局的证据确定性非常低。由于对不良事件的综合报告不足,对于该人群接受评估的手术干预措施的安全性,我们也存在非常低的确定性。因此,我们对这些干预措施治疗 INS 的相对疗效和安全性非常不确定。
本系统综述确定了与 INS 手术干预的疗效和安全性相关的最低限度高质量证据。鉴于这些手术是不可逆的,并且通常在儿童中进行,因此,临床医生在治疗 INS 时必须考虑到证据的局限性。需要更多的高质量 RCT 来更好地了解 INS 手术干预的疗效和安全性概况。这将有助于临床医生、INS 患者及其父母或照顾者做出基于证据的治疗决策。